<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="anaesthesia" lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher">JOHS</journal-id>
      <journal-id journal-id-type="nlm-ta">Journ of Health Scien</journal-id>
      <journal-title-group>
        <journal-title>Journal of HealthCare Sciences</journal-title>
        <abbrev-journal-title abbrev-type="pubmed">Journ of Health Scien</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2231-2196</issn>
      <issn pub-type="opub">0975-5241</issn>
      <publisher>
        <publisher-name>Radiance Research Academy</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">421</article-id>
      <article-id pub-id-type="doi">http://dx.doi.org/10.52533/JOHS.2025.50715</article-id>
      <article-id pub-id-type="doi-url"/>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Anaesthesia</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Use of Fentanyl in Pediatric Patients and Its Association with Postoperative Respiratory Events&#13;
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bayazeed</surname>
            <given-names>Feras Said</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Abualsaud</surname>
            <given-names>Noor Ayman</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alnasser</surname>
            <given-names>Osama Mohammed</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alqhtani</surname>
            <given-names>Mohammed Shaya</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="ppub">
        <day>23</day>
        <month>07</month>
        <year>2025</year>
      </pub-date>
      <volume>5</volume>
      <issue>7</issue>
      <fpage>364</fpage>
      <lpage>371</lpage>
      <permissions>
        <copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement>
        <copyright-year>2009</copyright-year>
        <license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Fentanyl is widely employed in pediatric anesthesia due to its rapid onset, potent analgesic properties, and favorable hemodynamic profile. Its use spans a range of procedures, from minor day-case surgeries to complex operations requiring deep sedation and prolonged analgesia. However, the pharmacologic advantages of fentanyl must be carefully weighed against its potential to induce postoperative respiratory events, particularly in young and vulnerable patients. Immature respiratory control mechanisms, reduced metabolic clearance, and altered protein binding in neonates and infants increase sensitivity to fentanyl__ampersandsign#39;s respiratory depressant effects. Variability in pharmacokinetics, driven by age, genetic polymorphisms, and comorbidities, further complicates standardized dosing. Postoperative respiratory events such as apnea, hypoventilation, airway obstruction, and oxygen desaturation are disproportionately common in pediatric patients administered fentanyl, especially those with conditions like obstructive sleep apnea, obesity, or neurological impairment. These events often occur during the immediate postoperative phase but may also present later during ward recovery, underscoring the importance of continued surveillance beyond the post-anesthesia care unit. Risk mitigation involves strategic dosing, use of non-opioid adjuncts, and regional anesthesia to reduce fentanyl exposure. Continuous monitoring through pulse oximetry and capnography enables earlier detection of respiratory compromise, improving clinical response times. Institutional protocols emphasizing individualized care, standardized monitoring, and multidisciplinary communication enhance safety in opioid-based pediatric pain management.&#13;
</p>
      </abstract>
      <kwd-group>
        <kwd>fentanyl</kwd>
        <kwd> pediatric anesthesia</kwd>
        <kwd> respiratory depression</kwd>
        <kwd> postoperative monitoring</kwd>
        <kwd> opioid safety</kwd>
      </kwd-group>
    </article-meta>
  </front>
</article>